Sildenafil Citrate Tablet, Film Coated
Product Images NDC 59762-0035

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 59762-0035). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sildenafil 01)

Chemical structure of sildenafil citrate, showing the molecular arrangement and bonds of the active ingredient in the drug.*

FDA Label Image

Figure 1 (Sildenafil 02)

A line graph depicting the effect of Sildenafil 100 mg versus placebo on systolic blood pressure over 24 hours post dose. The x-axis represents time in hours from pre-dose to 24 hours post dose, and the y-axis shows changes in systolic blood pressure in mmHg. Two lines compare the blood pressure variations between the Sildenafil and placebo groups over time.*

FDA Label Image

Figure 2 (Sildenafil 03)

A line graph depicting the change in systolic blood pressure (SBP) over time postdose (hours). It compares two conditions: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The vertical axis shows change in SBP in mmHg, and the horizontal axis shows time postdose in hours, with two lines representing the two conditions.*

FDA Label Image

Figure 3 (Sildenafil 04)

A line graph depicting the change in systolic blood pressure (SBP, mmHg) over time (hours) postdose. It compares two groups: one receiving Doxazosin plus Placebo and the other Doxazosin plus Sildenafil 50 mg, showing trends of SBP changes across an 8-hour period.*

FDA Label Image

Figure 4 (Sildenafil 05)

A line graph comparing blood pressure changes (in mmHg) over time (hours) after dosing with doxazosin plus sildenafil 100 mg versus doxazosin plus placebo. The x-axis shows time after dosing from 0 to 8 hours, and the y-axis shows blood pressure change from -50 to 40 mmHg. Two lines with different symbols represent each treatment group, indicating blood pressure trends over the measured period.*

FDA Label Image

Figure 5 (Sildenafil 06)

A line graph depicting plasma concentrations (ng/ml) of the commercial tablet formulation of Sildenafil Citrate over a 24-hour period post-dose. The graph shows plasma levels rising quickly to a peak within about one hour, then gradually declining over time until 24 hours after dosing.*

FDA Label Image

Figure 6 (Sildenafil 07)

Two bar graphs comparing the effect of Sildenafil Citrate versus placebo on maintenance of erection by baseline score. The x-axes show baseline scores 0 to 5; the y-axes show the percentage of patients at endpoint up to 80%. Different bar shades represent scores 0 to 5 in the response legend for each graph. The top graph illustrates Sildenafil Citrate data with increasing percentages at higher baseline scores, while the bottom graph shows placebo data with more variable percentages across scores.*

FDA Label Image

Figure 7 (Sildenafil 08)

Bar graph showing percentage of patients reporting improvement across treatment groups: Placebo (24%), Sildenafil Citrate 25 mg (63%), Sildenafil Citrate 50 mg (74%), and Sildenafil Citrate 100 mg (82%). The chart indicates an overall treatment effect with p-value less than 0.0001.*

FDA Label Image

Greenstone Logo (Sildenafil 09)

FDA Label Image

Greenstone Logo (Sildenafil 10)

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Label for sildenafil citrate 25 mg film-coated tablets by Greenstone LLC. The label shows 30 tablets in the package with storage instructions at 25°C (77°F) and excursions permitted between 15-30°C. Distributed by Greenstone LLC, Peapack, NJ, the product is made in Ireland. The label includes dosage form, strength, NDC 59762-0034-1, and barcodes.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

The label shows Sildenafil Citrate tablets, 50 mg strength, with Greenstone® Brand indicated. It is a prescription-only oral film-coated tablet package containing 30 tablets. The label identifies the distributor as Greenstone LLC, Peapack, NJ, and states the tablets are made in Ireland. Storage instructions and a barcode are also present.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Packaging label for sildenafil citrate tablets, 100 mg strength, by Greenstone LLC. The label indicates a package size of 30 film-coated tablets. It includes storage instructions, dosage form, and distributor information indicating the product is made in Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.